Stereotaxis, Inc. (NYSEAMERICAN:STXS) Sees Significant Drop in Short Interest

Stereotaxis, Inc. (NYSEAMERICAN:STXS) was the target of a significant drop in short interest during the month of November. As of November 30th, there was short interest totalling 2,540,000 shares, a drop of 17.3% from the November 15th total of 3,070,000 shares. Approximately 3.6% of the company’s shares are short sold. Based on an average daily volume of 291,600 shares, the days-to-cover ratio is presently 8.7 days.

Institutional Trading of Stereotaxis

Several institutional investors and hedge funds have recently made changes to their positions in the company. Barclays PLC lifted its holdings in Stereotaxis by 449.9% during the third quarter. Barclays PLC now owns 101,953 shares of the company’s stock worth $208,000 after buying an additional 83,412 shares during the period. Geode Capital Management LLC raised its position in shares of Stereotaxis by 7.2% in the 3rd quarter. Geode Capital Management LLC now owns 1,391,718 shares of the company’s stock worth $2,840,000 after acquiring an additional 93,253 shares in the last quarter. Jane Street Group LLC lifted its stake in shares of Stereotaxis by 26.9% during the 3rd quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock worth $61,000 after purchasing an additional 6,313 shares during the last quarter. State Street Corp boosted its position in Stereotaxis by 5.7% during the third quarter. State Street Corp now owns 680,612 shares of the company’s stock valued at $1,388,000 after purchasing an additional 36,518 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in Stereotaxis by 10.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company’s stock valued at $341,000 after purchasing an additional 15,491 shares during the last quarter. 45.35% of the stock is currently owned by institutional investors.

Stereotaxis Trading Up 6.8 %

NYSEAMERICAN STXS opened at $2.34 on Monday. The stock has a market capitalization of $198.27 million, a PE ratio of -8.36 and a beta of 1.57. Stereotaxis has a 12 month low of $1.63 and a 12 month high of $3.29.

Stereotaxis (NYSEAMERICAN:STXS) last issued its earnings results on Monday, November 11th. The company reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.03). Stereotaxis had a negative return on equity of 162.54% and a negative net margin of 85.79%. The company had revenue of $9.20 million during the quarter, compared to the consensus estimate of $6.80 million. As a group, equities research analysts anticipate that Stereotaxis will post -0.26 earnings per share for the current year.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.